2006
Assessment of HIV Testing of Urban Injection Drug Users: Implications for Expansion of HIV Testing and Prevention Efforts
Heimer R, Grau LE, Curtin E, Khoshnood K, Singer M. Assessment of HIV Testing of Urban Injection Drug Users: Implications for Expansion of HIV Testing and Prevention Efforts. American Journal Of Public Health 2006, 97: 110-116. PMID: 17138916, PMCID: PMC1716244, DOI: 10.2105/ajph.2005.078105.Peer-Reviewed Original ResearchMeSH KeywordsAdultAIDS SerodiagnosisBlood-Borne PathogensDiagnostic ServicesEquipment ContaminationFemaleHealth EducationHIV SeropositivityHIV SeroprevalenceHumansMaleMiddle AgedNeedle-Exchange ProgramsProgram EvaluationPublic Health AdministrationSubstance Abuse, IntravenousSyringesUnited StatesUrban Health ServicesConceptsUrban injection drug usersInjection drug usersHIV testingDrug usersUndetected infectionsHIV prevention strategiesExtent of HIVTime-location samplingSecondary preventionDrug treatmentSyringe exchangeHIVPrevention effortsCurrent optionsInfectionChain referralVast majorityTestingReferralPreventionWomen
2002
Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990–2001
Heimer R, Clair S, Teng W, Grau LE, Khoshnood K, Singer M. Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990–2001. Journal Of Urban Health 2002, 79: 556-570. PMID: 12468675, PMCID: PMC3456719, DOI: 10.1093/jurban/79.4.556.Peer-Reviewed Original ResearchConceptsSyringe exchange programsClean syringesHuman immunodeficiency virus (HIV) prevalenceHuman immunodeficiency virus (HIV) transmissionSyringe exchange useSyringe trackingHIV riskSyringe availabilityNumber of syringesVirus prevalenceVirus transmissionSyringesVisitsRiskNew HavenEffect of legislationPrevalenceEthical Dilemmas Created by the Criminalization of Status Behaviors: Case Examples from Ethnographic Field Research with Injection Drug Users
Buchanan D, Khoshnood K, Stopka T, Shaw S, Santelices C, Singer M. Ethical Dilemmas Created by the Criminalization of Status Behaviors: Case Examples from Ethnographic Field Research with Injection Drug Users. Health Education & Behavior 2002, 29: 30-42. PMID: 11822551, DOI: 10.1177/109019810202900105.Peer-Reviewed Original Research
2000
Syringe source, use, and discard among injection-drug users in New Haven, Connecticut.
Khoshnood K, Blankenship KM, Pollack HA, Roan CT, Altice FL. Syringe source, use, and discard among injection-drug users in New Haven, Connecticut. AIDS & Public Policy Journal 2000, 15: 88-94. PMID: 12189714.Peer-Reviewed Original Research
1998
Syringe Use and Reuse: Effects of Syringe Exchange Programs in Four Cities
Heimer R, Khoshnood K, Bigg D, Guydish J, Junge B. Syringe Use and Reuse: Effects of Syringe Exchange Programs in Four Cities. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: s37-s44. PMID: 9663622, DOI: 10.1097/00042560-199802001-00008.Peer-Reviewed Original Research
1996
Hepatitis in Used Syringes: The Limits of Sensitivity of Techniques to Detect Hepatitis B Virus (HBV) DNA, Hepatitis C Virus (HCV) RNA, and Antibodies to HBV Core and HCV Antigens
Heimer R, Khoshnood K, Jariwala-Freeman B, Duncan B, Harima Y. Hepatitis in Used Syringes: The Limits of Sensitivity of Techniques to Detect Hepatitis B Virus (HBV) DNA, Hepatitis C Virus (HCV) RNA, and Antibodies to HBV Core and HCV Antigens. The Journal Of Infectious Diseases 1996, 173: 997-1000. PMID: 8603983, DOI: 10.1093/infdis/173.4.997.Peer-Reviewed Original ResearchConceptsHepatitis C virus RNAHepatitis B virus DNAHepatitis virus infectionC virus RNAB virus DNAPolymerase chain reactionVirus infectionVirus DNAHBV core antigenVirus RNANeedle exchange programsHCV antibodiesHCV antigensCore antigenHBV coreUsed syringesPCR testingSyringe useDrug usersHCVHBVChain reactionAntibodiesMean limitSyringes
1993
Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut
Heimer R, Kaplan E, Khoshnood K, Jariwala B, Cadman E. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. The American Journal Of Medicine 1993, 95: 214-220. PMID: 8356986, DOI: 10.1016/0002-9343(93)90263-o.Peer-Reviewed Original ResearchConceptsHIV-1 proviral DNANeedle exchange programsProviral DNANew Haven's needle exchange programNeedle exchangeHIV-1 prevalenceIntravenous drug usersNeedle exchange clientsDrug treatment programsPercentage of syringesDrug use habitsSyringe trackingDNA prevalenceNew HavenPolymerase chain reactionDrug treatmentDrug usersTreatment programPrevalenceChain reactionExchange programsSyringesMonthsProgram participantsFunded evaluation